Is tetracaine safe to use during pregnancy?

Is Tetracaine Safe During Pregnancy?

Tetracaine can be used during pregnancy when clinically necessary, but should be limited to the lowest effective dose and shortest duration, as there is insufficient human safety data and it should be avoided unless no safer alternative exists.

Evidence Assessment

The available evidence regarding tetracaine use in pregnancy is notably limited. No guidelines or drug labels specifically address tetracaine safety during pregnancy in the provided evidence. The FDA drug label for tetracaine 1 provides only basic formulation information without pregnancy-specific guidance, and the warnings 1 focus on external use precautions without mentioning pregnancy.

General Local Anesthetic Safety Framework

While tetracaine-specific pregnancy data is lacking, the broader context of local anesthetic use during pregnancy provides guidance:

Established Safe Local Anesthetics in Pregnancy

Lidocaine is the preferred local anesthetic during pregnancy 2, 3. Animal studies show no evidence of fetal harm with infiltrated lidocaine, earning it FDA pregnancy category B status 2. Multiple studies demonstrate safety:

• A prospective study of 210 pregnancies exposed to dental local anesthetics (primarily lidocaine with epinephrine) showed no significant difference in major anomalies (4.8% vs 3.3% in controls), miscarriages, gestational age, or birth weight 4
• A systematic review of 1,954 patients receiving local anesthetics (primarily lidocaine) during pregnancy found no significant differences in adverse pregnancy outcomes 5

Topical Anesthetic Considerations

Guidelines recommend against using non-lidocaine topical anesthetics in pregnant women 2. This recommendation is based on expert opinion due to insufficient safety data for alternatives.

Tetracaine-Specific Concerns

Pediatric Safety Signals

While not directly applicable to pregnancy, tetracaine has demonstrated concerning adverse effects in vulnerable populations:

• Arrhythmia in extremely low birth weight infants: A case report documented clinically significant bradycardia after topical tetracaine application 6
• Contact dermatitis and bradycardia: Another preterm infant experienced both bradycardia and severe skin desquamation after tetracaine exposure 7
• These events raise concerns about systemic absorption and toxicity potential

Limited Efficacy Data

Recent pediatric guidelines suggest tetracaine-containing creams only when rapid cannulation is required (within 30-60 minutes), with EMLA preferred for standard procedures 8. This reflects concerns about the risk-benefit profile.

Clinical Decision Algorithm

When topical anesthesia is needed during pregnancy:

1. First-line: Use lidocaine-based topical preparations (FDA category B, established safety profile)

2. If tetracaine is being considered:

   • Confirm no lidocaine-based alternative is available
   • Use only for essential procedures where benefit clearly outweighs unknown fetal risk
   • Apply minimum effective amount to smallest necessary area
   • Limit application time to reduce systemic absorption
   • Avoid use during first trimester when organogenesis occurs (highest teratogenic risk period)

3. Contraindications to tetracaine use:

   • Large surface areas or raw/blistered skin (increased systemic absorption) 1
   • Non-essential cosmetic procedures
   • When safer alternatives exist

Key Caveats

• No human pregnancy data exists for tetracaine specifically, making risk assessment impossible
• The general principle that "it is best to avoid all antihistamines in pregnancy, especially during the first trimester" 9 applies similarly to medications without established pregnancy safety
• Systemic absorption risk: Tetracaine's documented adverse effects in neonates 6, 7 suggest potential for systemic toxicity that could theoretically affect the fetus
• The guideline recommendation against non-lidocaine topical anesthetics in pregnancy 2 should be interpreted to include tetracaine

Bottom Line

Given the absence of pregnancy safety data for tetracaine, the availability of safer alternatives (lidocaine), and documented adverse effects in vulnerable populations, tetracaine should be avoided during pregnancy unless absolutely necessary and no safer option exists. When used, apply the minimum amount for the shortest duration, particularly avoiding the first trimester.